In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
199 News Items found
Mount Rushmore viewed through face-detection software.
Making a Splash: Researchers Apply Face-Detection Technology to the Study of Genes

Taking a cue from smartphone technology, scientists are using face-recognition algorithms to improve RNA interference.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
Taking the STING Out of Cancer: Discovery about How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach

The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Sara Teichholtz stands in front of the water holding her son.
How Routine Prenatal Tests Can Detect Cancer and What It Means for Pregnant Women 

Learn how noninvasive prenatal tests designed to screen for genetic abnormalities in the fetus may detect the presence of cancer in pregnant women.
Dr. Alicia Latham, Dr. Michael Walsh, Dr. Zsofia Stadler, and Megha Ranganathan
Feature
Inherited Cancer Risks: New Insights from MSK Presented at 2023 ASCO Meeting

MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
Dr. Lisa DeAngelis
Cancer Is Not Going Away During COVID-19: Physician-in-Chief Lisa DeAngelis Shares Why Patients Need to Get Back to the Clinic

Cancer institutions need to be vigilant in their approach to getting patients safely back to the clinic so they don’t further delay life-saving care.
Graphical representation of cells leaking into bloodstream
In the Lab
What Does Cancer Metastasis Have to Do with Wound Healing? More than You Might Think

Scientists are learning that — in a literal sense — metastasis is wound healing gone wrong.
MSK Doctors Andrea Cercek and Michael Foote are seen smiling.
Treating HER2-Amplified Early-Stage Rectal Cancer To Improve Quality of Life

Learn how rectal cancer patients with HER2 driven tumors benefited from an early stage clinical trial at MSK.
Dandelion
Seed and Soil: Tracing the Journey of Spreading Cancer Cells

MSK researchers are learning more about how cancer cells can survive undetected for years only to return in new places. These insights will guide future therapies.
Dana Pe'er and Scott Lowe
Expansion of Cell-to-Cell Communication Drives the Early Development of Pancreatic Cancer, New Research in Mice Finds

New MSK research combined sophisticated genetically engineered mouse models and advanced computational methods to map the earliest cell states leading to pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer.
This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.
In the Lab
Scientists Identify Growth Signal for Metastatic Cancer "Seeds"

Targeting this signal with drugs might be one way to stop cancers from spreading.